218 related articles for article (PubMed ID: 27434352)
1. The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.
He H; Guo J; Zhang A
Int J Cardiol; 2016 Oct; 221():827-30. PubMed ID: 27434352
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
[TBL] [Abstract][Full Text] [Related]
3. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation.
Abumuaileq RR; Abu-Assi E; López-López A; Raposeiras-Roubin S; Rodríguez-Mañero M; Martínez-Sande L; García-Seara J; Fernandez-López XA; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2015 Nov; 15():156. PubMed ID: 26584938
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
5. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
Chao TF; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Hsieh MH; Chen SA
Can J Cardiol; 2014 Apr; 30(4):405-12. PubMed ID: 24582725
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of ATRIA versus CHA
Zhu W; Fu L; Ding Y; Huang L; Xu Z; Hu J; Hong K
Int J Cardiol; 2017 Jan; 227():436-442. PubMed ID: 27839802
[TBL] [Abstract][Full Text] [Related]
7. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
8. Relation of red blood cell distribution width with CHADS
Liu T; Shao Q; Korantzopoulos P; Miao S; Zhang Z; Xu G; Yuan R; Li G
Int J Cardiol; 2017 Feb; 228():861-864. PubMed ID: 27889552
[TBL] [Abstract][Full Text] [Related]
9. External validation and comparison of CHA
Zheng N; Zhang J
J Interv Card Electrophysiol; 2022 Nov; 65(2):535-542. PubMed ID: 35831771
[TBL] [Abstract][Full Text] [Related]
10. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
11. Predicting a decrease in left atrial appendage flow velocity using left atrial diameter and CHA
Wang G; Li G; Hu F; Zang M; Pu J
BMC Cardiovasc Disord; 2023 Apr; 23(1):180. PubMed ID: 37013469
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the evaluation of acute ischemic stroke risk in individuals with non-valvular atrial fibrillation by including laboratory indicators.
Hou X; Zhang X
Sci Rep; 2024 Mar; 14(1):6844. PubMed ID: 38514850
[TBL] [Abstract][Full Text] [Related]
13. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.
Zhang Y; Yuan YQ
Arq Bras Cardiol; 2021 Feb; 116(2):325-331. PubMed ID: 33470330
[TBL] [Abstract][Full Text] [Related]
14. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
[TBL] [Abstract][Full Text] [Related]
15. CHADS
Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CHA
Hu WS; Lin CL
Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
[TBL] [Abstract][Full Text] [Related]
17. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA₂DS₂-VASc score.
Chao TF; Tsao HM; Ambrose K; Lin YJ; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Chung FP; Hanafy DA; Lin WY; Chen SA
Heart Rhythm; 2012 Nov; 9(11):1755-60. PubMed ID: 22760084
[TBL] [Abstract][Full Text] [Related]
18. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
19. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
Saliba W; Rennert G
Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA
Kamili K; Zheng T; Luo C; Wang X; Tian G
Lipids Health Dis; 2024 Jan; 23(1):22. PubMed ID: 38254171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
